Dr. Lee Ratner, MD
Claim this profileWashington University School of Medicine
Studies Lymphoma
Studies Kaposi's Sarcoma
11 reported clinical trials
30 drugs studied
Area of expertise
1Lymphoma
Stage IV
CD20 positive
CD20 negative
2Kaposi's Sarcoma
Affiliated Hospitals
Clinical Trials Lee Ratner, MD is currently running
Lenalidomide + EPOCH Chemotherapy
for Adult T-Cell Leukemia-Lymphoma
This phase I trial studies the side effects and best dose of lenalidomide when given together with usual combination chemotherapy (etoposide, prednisone, vincristine sulfate \[Oncovin\], cyclophosphamide, and doxorubicin hydrochloride \[hydroxydaunorubicin hydrochloride\], or "EPOCH") in treating adult T-cell leukemia-lymphoma. Lenalidomide may help shrink or slow the growth of adult T-cell leukemia-lymphoma. Drugs used in chemotherapy, such as etoposide, vincristine, cyclophosphamide, and doxorubicin, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Anti-inflammatory drugs such as prednisone lower the body's immune response and are used with other drugs in the treatment of some types of cancer. Giving lenalidomide and the usual combination chemotherapy may work better in treating adult T-cell leukemia-lymphoma compared to the usual combination chemotherapy alone.
Recruiting1 award Phase 1
Smoking Cessation Intervention
for HIV/AIDS
This clinical trial evaluates the usefulness of using a smartphone-based HIV-specific smoking cessation intervention at the time of lung cancer screening in helping people living with HIV quit smoking. Positively Smoke Free - Mobile may help patients with HIV quit smoking.
Recruiting1 award N/A8 criteria
More about Lee Ratner, MD
Clinical Trial Related1 year of experience running clinical trials · Led 11 trials as a Principal Investigator · 7 Active Clinical TrialsTreatments Lee Ratner, MD has experience with
- Propranolol
- Recombinant EphB4-HSA Fusion Protein
- Smoking Cessation Intervention
- Nicotine Replacement
- Screening Tool
- Non-Interventional Follow-up
Breakdown of trials Lee Ratner, MD has run
Lymphoma
Kaposi's Sarcoma
Kaposi Sarcoma
HIV/AIDS
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Lee Ratner, MD specialize in?
Lee Ratner, MD focuses on Lymphoma and Kaposi's Sarcoma. In particular, much of their work with Lymphoma has involved Stage IV patients, or patients who are CD20 positive.
Is Lee Ratner, MD currently recruiting for clinical trials?
Yes, Lee Ratner, MD is currently recruiting for 6 clinical trials in Saint Louis Missouri. If you're interested in participating, you should apply.
Are there any treatments that Lee Ratner, MD has studied deeply?
Yes, Lee Ratner, MD has studied treatments such as Propranolol, Recombinant EphB4-HSA Fusion Protein, Smoking Cessation Intervention.
What is the best way to schedule an appointment with Lee Ratner, MD?
Apply for one of the trials that Lee Ratner, MD is conducting.
What is the office address of Lee Ratner, MD?
The office of Lee Ratner, MD is located at: Washington University School of Medicine, Saint Louis, Missouri 63110 United States. This is the address for their practice at the Washington University School of Medicine.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.